VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platformPUBT·Aug 26 at 01:17 PMVNRX-0.09%SSMXY-0.24%
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets | VNRX Stock NewsStockTitan·Aug 26 at 05:17 AMVNRX-0.09%SSMXY-0.24%
Yesway Reports Q2 2026 Results: Full Earnings Call Transcriptbenzinga_article·Aug 13 at 01:42 PMYSWY+3.16%
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update | VNRX Stock NewsStockTitan·Aug 13 at 12:10 PMVNRX-0.09%
Sysmex releases transcript of Q1 FY2027 financial results presentationPUBT·Aug 12 at 07:17 AMSSMXY-0.24%6869
Sysmex: Strong sales and profit growth, with raised outlook and higher dividends, led by Japan and AmericasQuartr·Aug 7 at 06:47 AMSSMXY-0.24%6869
Sysmex Q1 FY27 profit more than doubles to JPY 8.62 billion; net sales rise 23.6% to JPY 130.67 billionPUBT·Aug 7 at 06:33 AMSSMXY-0.24%6869
VolitionRx Announces Collaboration with Sysmex | VNRX Stock NewsStockTitan·Jun 17 at 04:15 AMVNRX-0.09%SSMXY-0.24%
17:30 ETSysmex America Introduces Next Generation XR-Series™ Hematology Solution for Clinical Laboratoriesprnewswire·May 28 at 09:30 PM6869SSMXY-0.24%
